Advertisement
Central Universities Recruitment Exam

CUREC 2023: Registration Deadline Extended; Know How To Apply Here

Our Correspondent
Posted on 22 Dec 2023
10:08 AM
File Image
Summary
The National Testing Agency (NTA) has extended the registration window for the Central Universities Recruitment Exam (CUREC) 2023
The selection process for CUREC 2023 includes multiple stages, including a written exam, skill test (as per post requirement), document verification, and a medical examination

The National Testing Agency (NTA) has extended the registration window for the Central Universities Recruitment Exam (CUREC) 2023. Originally set to conclude on December 21, the registration period has now been extended until December 26. Aspiring candidates can complete the NTA CUREC 2023 application process on the official website exams.nta.ac.in.

The selection process for CUREC 2023 includes multiple stages, including a written exam, skill test (as per post requirement), document verification, and a medical examination.

Steps to apply for CUREC 2023:

Advertisement

1. Visit the official website at exams.nta.ac.in.

2. Navigate to the homepage and select the registration option.

3. Complete the registration form by providing essential details such as name, email id, and contact information.

4. Log in using the credentials generated during registration.

5. Fill out the application form with the required details.

6. Upload necessary documents and proceed with the fee payment.

7. Download and retain a printout of the confirmation page for reference.

Last updated on 22 Dec 2023
10:08 AM
Central Universities Recruitment Exam CUREC 2023
Advertisement
Similar stories
NEET SS 2025

NEET SS Counselling 2025-26: NMC Approves 40+ Additional Seats; Check Updated List

delhi schools

Delhi Schools Reopen - DoE Issues Guidelines to Identify Learning Gaps, Boost Interac. . .

WBCHSE

WB HS 2027 Semester System Scrapped Off? WBCHSE Dismisses Fake Notice, Files FIR

CBSE 2026

CBSE 2026: Board Clarifies QR Code Rumours on Question Papers; Issues Advisory

read next